Pharming Group N.V.

PHAR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$9.82-2.58%

2026-08-03

Financials

Valuation Metrics

Pharming Group N.V.'s Market Cap is $694M. At end of 2025 it was $1.17B. Ranked #2664 of 3,112 in US market (top 86%), #1129 of 1,445 on NASDAQ (top 78%), #211 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 78%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$694M	US#2,664/3,112 Sec#211/269
Revenue	$369M	US#2,468/3,112 Sec#90/269
Net Income	$12M	US#2,127/3,112 Sec#71/269
Total Assets	$489M	US#2,750/3,112 Sec#160/269
Net Assets	$269M	US#2,612/3,112 Sec#172/269
Value
P/E	56.25x	US#1,897/3,112 Sec#60/269
P/B	2.58x	US#1,498/3,112 Sec#72/269
P/S	1.88x	US#1,195/3,112 Sec#26/269
EV/EBITDA	17.32x	US#1,693/3,112 Sec#48/269
FCF Yield	7.22%	US#842/3,112 Sec#31/269
Profitability
ROE	4.58%	US#1,875/3,112 Sec#65/269
ROA	2.52%	US#1,501/3,112 Sec#64/269
Op. Margin	6.33%	US#1,937/3,112 Sec#73/269
Revenue Growth	-8.40%	US#2,625/3,112 Sec#144/269
Financial Health
Debt Ratio	81.95%	US#892/3,112 Sec#158/269
Total Debt	$116M	US#2,342/3,112 Sec#111/269
FCF	$50M	US#1,932/3,112 Sec#68/269
Cash	$53M	US#2,554/3,112 Sec#223/269
Current Ratio	2.63x	US#946/3,112 Sec#206/269
Net Debt/EBITDA	1.44x	US#1,182/3,112 Sec#54/269
Performance
1Y Return	-10.40%	US#2,582/3,112 Sec#219/269
1M Return	-28.69%	US#3,054/3,112 Sec#255/269
From 52W High	-53.98%	US#2,851/3,112 Sec#228/269
1Y MDD	-53.64%	US#2,531/3,112 Sec#195/269
Trading
Volume	33,754 shares	US#3,081/3,112 Sec#267/269
Trading Value	$335514.00	US#3,092/3,112 Sec#267/269
Per Share
EPS	$0.04	US#2,047/3,112 Sec#74/269
BPS	$4.18	US#2,298/3,112 Sec#144/269